AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 4602899
Drug: RA27/3 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA27/3 vaccine
Trial: 619075
Drug: Cendehill vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cendehill vaccine
Trial: 31400515
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of CBT and modafinil for 12 weeks
Trial: 31400515
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of CBT and modafinil
Trial: 28203020
Drug: CFNB combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CFNB combined with PLIA (20 mL ropivacaine 5 g/L)
Trial: 16763334
Drug: IFN‐a2a (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐a2a (9 MU three times a week) and lamivudine (100 mg daily) for 12 months (Group 1)
Trial: 17040264
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment 0.1%
Trial: 9024746
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogen (0.625 mg/day of Premarin)
Trial: 7744191
Drug: Bambuterol 10
RxNorm normalized name: bambuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 10 mg
Trial: 7744191
Drug: Bambuterol 20
RxNorm normalized name: bambuterol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 20 mg
Trial: 8299660
Drug: Terbutaline 7.5
RxNorm normalized name: terbutaline 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 7.5 mg
Trial: 8299660
Drug: Bambuterol 10
RxNorm normalized name: bambuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 10 mg vs Terbutaline 7.5 mg
Trial: 8299660
Drug: Bambuterol 10
RxNorm normalized name: bambuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 10 mg vs Bambuterol 20 mg
Trial: 8299660
Drug: Bambuterol 20
RxNorm normalized name: bambuterol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol 20 mg vs Terbutaline high dose
Trial: 3571318
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment of ligamentous injuries
Trial: 3571318
Drug: Non-surgical treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical treatment of ligamentous injuries
Trial: 26433763
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) in routine care
Trial: 26433763
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) in RCTs
Trial: 25551813
Drug: Combined sciatic-femoral
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sciatic-femoral nerve block with levobupivacaine 0.5% (40 ml)
Trial: 25551813
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with 7.5 mg levobupivacaine 0.5%
Trial: 22286203
Drug: aripiprazole 2
RxNorm normalized name: aripiprazole 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aripiprazole 2 mg/day
Trial: 16330624
Drug: Systematic detection
RxNorm normalized name: alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoic acid / docusate sodium / ferrous fumarate / folic acid / pyridoxine hydrochloride / tricalcium phosphate Oral Capsule [Nexa Select]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic detection and multidisciplinary treatment of depression (consultation and treatment by a psychiatrist, follow-up by a research nurse and family physician)
Trial: 12698500
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg bid of theophylline (Unilong)
Trial: 12698500
Drug: 375 mg
RxNorm normalized name: niacin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg bid of theophylline (Unilong)
Trial: 10648261
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L unfiltered cafetière (French press) coffee daily for 2 weeks
Trial: 3321397
Drug: Low-dose antacid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antacid treatment with additional ranitidine
Trial: 3321397
Drug: Low-dose antacid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antacid treatment without ranitidine
Trial: 30591198
Drug: Topical diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diltiazem applied three times a day
Trial: 28931618
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants (warfarin)
Trial: 22554354
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg day(‐1) for 4 days)
Trial: 22554354
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg day(‐1) for 6 days)
Trial: 22567069
Drug: Biofeedback-based stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback-based stress management tool used three times daily
Trial: 10630736
Drug: Bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10 mg daily for 12 weeks
Trial: 10630736
Drug: Nitrendipine 20
RxNorm normalized name: nitrendipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 20 mg daily for 12 weeks
Trial: 6391236
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 50 g of glucose added to porcine insulin (0.4 Ul.g-1)
Trial: 6391236
Drug: Glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusion without insulin
Trial: 29351748
Drug: Medication (acetaminophen)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (acetaminophen)
Trial: 24557758
Drug: Mydriasert (ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mydriasert (ophthalmic insert containing tropicamide and phenylephrine)
Trial: 22089379
Drug: Raltegravir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir (400 mg twice/day)
Trial: 9495425
Drug: Granisetron 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 2.5 mg (Group G)
Trial: 2258249
Drug: SR nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR nicardipine (40 mg b.i.d.)
Trial: 2684073
Drug: Chlorthalidone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (25 mg once daily)
Trial: 27830643
Drug: Simulator-based occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulator-based occupational therapy driving intervention (OT-DI); 3 sessions addressing driving errors and visual-search retraining
Trial: 24809482
Drug: Group S
RxNorm normalized name: Blood group substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group S (shallow block) with rocuronium 0.45 mg kg-1
Trial: 24809482
Drug: Group D
RxNorm normalized name: Prostaglandin group D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group D (deep block) with rocuronium 0.6 mg kg-1
Trial: 20379032
Drug: Cold polymerized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold polymerized soft liner (Visco Gel)
Trial: 17524123
Drug: New 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New 4% hydroquinone cream
Trial: 17524123
Drug: Commercial 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial 4% hydroquinone creams
Trial: 16253600
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/day (n = 48)
Trial: 16253600
Drug: no lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no lipid-lowering treatment (n = 43)
Trial: 11876795
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU of IFN-alpha thrice weekly for 24 weeks
Trial: 1690551
Drug: Oral ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral ribavirin 600 mg
Trial: 1690551
Drug: Oral ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral ribavirin 800 mg
Trial: 42523
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg cimetidine and 50 mg methanthelinebromide
Trial: 42523
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg methanthelinebromide
Trial: 31416768
Drug: MTBVAC (5×10^5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTBVAC (5×10^5 CFU in 0.1 mL)
Trial: 31416768
Drug: BCG Vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG Vaccine SSI (5×10^5 CFU in 0.1 mL)
Trial: 31416768
Drug: MTBVAC (2.5×10^3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTBVAC (2.5×10^3 CFU in 0.05 mL)
Trial: 31416768
Drug: MTBVAC (2.5×10^4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTBVAC (2.5×10^4 CFU in 0.05 mL)
Trial: 31416768
Drug: MTBVAC (2.5×10^5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTBVAC (2.5×10^5 CFU in 0.05 mL)
Trial: 31416768
Drug: BCG Vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG Vaccine SSI (2.5×10^5 CFU in 0.05 mL)
Trial: 25771480
Drug: Other hand
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other hand therapy treatments (control)
Trial: 22561230
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg once daily for 24 weeks
Trial: 22561230
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg once daily for 24 weeks
Trial: 16499476
Drug: Acetazolamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (250 mg, orally, three times a day for 2 days)
Trial: 12521832
Drug: 17‐beta oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17‐beta oestradiol 25‐mg vaginal tablets
Trial: 9773136
Drug: Very slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very slow injection of local anaesthetic (injection time 100 to 150 seconds, Group A)
Trial: 9773136
Drug: Faster injection
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Faster injection of local anaesthetic (injection time 40 to 80 seconds, Group B)
Trial: 600190
Drug: Timolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (5 mg to 20 mg) with hydrochlorothiazide
Trial: 600190
Drug: Moduretic (hydrochlorothiazide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moduretic (hydrochlorothiazide, 50 mg and amiloride, 5 mg) with timolol
Trial: 29083391
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (traction, strengthening, stretching exercises)
Trial: 23284039
Drug: Complete resection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete resection before chemotherapy
Trial: 23284039
Drug: Incomplete resection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incomplete resection before chemotherapy
Trial: 23284039
Drug: Biopsy or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biopsy or no surgery before chemotherapy
Trial: 23284039
Drug: Complete resection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete resection after induction chemotherapy
Trial: 23284039
Drug: Incomplete resection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incomplete resection after induction chemotherapy
Trial: 23284039
Drug: Biopsy or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biopsy or no surgery after induction chemotherapy
Trial: 18851852
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (2 g of elemental calcium)
Trial: 16281880
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg isotretinoin + 0.05% tretinoin cream
Trial: 16281880
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg isotretinoin + 0.05% tretinoin cream
Trial: 16281880
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg isotretinoin/kg bodyweight + 0.05% tretinoin cream + oral methylprednisolone
Trial: 16281880
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg isotretinoin/kg bodyweight + 0.05% tretinoin cream
Trial: 11724639
Drug: Candesartan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (8 mg acute, titrated to 16 mg daily chronic)
Trial: 31482417
Drug: Gentamicin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 2.5 mg/kg every 12 hours (Group 1)
Trial: 31482417
Drug: Gentamicin 4
RxNorm normalized name: gentamicin 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 4 mg/kg every 36 hours (Group 2)
Trial: 31482417
Drug: No Gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Gentamicin therapy (Group 3)
Trial: 28279833
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg sc weekly for 26 weeks
Trial: 16225841
Drug: Task Concentration
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Task Concentration Training (TCT) combined with Cognitive Therapy (CT)
Trial: 27504532
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (ESWT) applied to one side of the jaw
Trial: 22666779
Drug: 4% succinylated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% succinylated gelatin (gelofusine solution) (group JEL)
Trial: 15709546
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral immunonutrition for 5 days
Trial: 15709546
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (no supplementation)
Trial: 12408922
Drug: Formulation R
RxNorm normalized name: Formulation R
DrugBank: Hydrogenated palm kernel oil (DB11144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation R (400 mg)
Trial: 12408922
Drug: Formulation T
RxNorm normalized name: ABANEU-SL Cobalamin Complex Formulation Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation T (400 mg)
Trial: 7497762
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (800 micrograms/d)
Trial: 6120713
Drug: Astemizole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole (20 mg)
Trial: 23574730
Drug: Sitagliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (50 mg/day)
Trial: 19204211
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids vs placebo
Trial: 19204211
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids and long-acting β-agonists vs long-acting β-agonists
Trial: 14769141
Drug: Plasma exchange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma exchange plus conventional cancer chemotherapy
Trial: 14769141
Drug: Plasma exchange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma exchange plus continuous oral cyclophosphamide
Trial: 11677866
Drug: Bisoprolol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol therapy
Trial: 7527328
Drug: Lacidipine 2
RxNorm normalized name: lacidipine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 2 to 8 mg/day for 1 to 4 months
Trial: 7527328
Drug: Lacidipine 4
RxNorm normalized name: lacidipine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine 4 to 6 mg once daily
Trial: 23070789
Drug: Flavonoid-rich juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavonoid-rich juice (JUICE) 16 fl oz (230 mg flavonoids) ingested pre- and postworkout for 10 days
Trial: 30194618
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion sonohysterography (SIS)
Trial: 18405345
Drug: Dispensing medication
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dispensing medication packaged in the electronic medication-monitoring device
Trial: 18405345
Drug: Conventional medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medication packaging
Trial: 9097297
Drug: d,l-fenfluramine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d,l-fenfluramine (60 mg p.o.)
Trial: 3080695
Drug: Acute intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute intravenous TRH (500 mg)
Trial: 3080695
Drug: Chronic subcutaneous
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic subcutaneous TRH (25 mg daily for 3 months)
Trial: 27741339
Drug: 4% 5-Fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% 5-Fluorouracil cream once daily for 4 weeks
Trial: 27741339
Drug: 5% 5-Fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% 5-Fluorouracil cream twice daily for 4 weeks
Trial: 27741339
Drug: 4% 5-Fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% 5-Fluorouracil cream once daily for 2 weeks
Trial: 19897255
Drug: Home-based daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based daily muscle training for 12 months
Trial: 15723739
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil omega-3 fatty acids (3 g/d)
Trial: 15723739
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil omega-3 fatty acids (3 g/d) and olive oil (9.6 mL)
Trial: 12793996
Drug: 1-g aspirin
RxNorm normalized name: aspirin 1 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-g aspirin treatment
Trial: 12545825
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + PA-MSHA vaccine
Trial: 8806338
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers and No drug therapy (Control)
Trial: 29722146
Drug: Intravenous esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous esomeprazole 4 hours before EST and then every 12 hours for 1 day, followed by high-dose oral esomeprazole for 10 days
Trial: 22681960
Drug: Intravenous esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous esomeprazole
Trial: 26540314
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m²) and oxaliplatin (100 mg/m²) with panitumumab (6 mg/kg) for up to 12 cycles (arm A)
Trial: 26540314
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m²) and oxaliplatin (100 mg/m²) without panitumumab (arm B)
Trial: 20386070
Drug: bosentan (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bosentan (125 mg twice daily) and lopinavir/ritonavir (400/100 mg twice daily)
Trial: 20386070
Drug: lopinavir/ritonavir (400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir (400/100 mg twice daily)
Trial: 10206447
Drug: Metformin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1.5 to 2.25 g/d) for 6.1+/‐5.1 months
Trial: 10206447
Drug: Metformin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1.5 to 2.25 g/d)
Trial: 8580383
Drug: RFLP‐A polymorphism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RFLP‐A polymorphism of the interleukin 1 receptor type I gene (IL1RI)
Trial: 8580383
Drug: RFLP‐B polymorphism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RFLP‐B polymorphism of the interleukin 1 receptor type I gene (IL1RI)
Trial: 613552
Drug: Parenteral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral treatment with triamcinolone acetonide (Kenacort A) - 80 mg for the 1st and 2nd injections, 40 mg for the 3rd to 7th injections at two-week intervals
Trial: 613552
Drug: Parenteral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral treatment with triamcinolone acetonide (Kenacort A)